Financials and Filings

MGEN $7.63   $ (0.19) (2.55)%

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
8-K 8-K 11/15/2017 11/14/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; and Financial Statements and Exhibits.
10-Q 10-Q 11/9/2017 9/30/2017
8-K 8-K 11/8/2017 11/8/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition; Other Events; and Financial Statements and Exhibits.
8-K 8-K 10/13/2017 10/13/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 9/11/2017 9/11/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
13-D SC 13D/A 8/16/2017
8-K 8-K 8/11/2017 8/10/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Other Events; and Financial Statements and Exhibits.
10-Q 10-Q 8/11/2017 6/30/2017
8-K 8-K 6/30/2017 6/28/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Submission of Matters to a Vote of Security Holder.
8-K 8-K 6/8/2017 6/8/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
10-Q 10-Q/A 6/7/2017 3/31/2017
8-K 8-K 6/5/2017 6/5/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 5/24/2017 5/24/2017
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
Proxy DEF 14A 5/15/2017 6/28/2017
Proxy DEFA14A 5/15/2017
10-Q 10-Q 5/11/2017 3/31/2017
8-K 8-K 5/10/2017 5/10/2017
Abstract: 8-K filed by Miragen Therapeutics covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 5/3/2017 5/2/2017
Abstract: 8-K filed by Miragen Therapeutics covering Entry into a Material Definitive Agreement and Financial Statements and Exhibits.
13-D SC 13G 4/3/2017
8-K 8-K 3/31/2017 3/31/2017
Abstract: 8-K filed by Miragen Therapeutics covering Entry into a Material Definitive Agreement; Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; and Financial Statements and Exhibits.

Displaying 1 to 20 (of 139 filings)